# Baseline Concentration of Direct Oral Anticoagulant and Incidence of Adverse Event Measure And See (MAS)

> **NCT03803579** · — · COMPLETED · sponsor: **Arianna Anticoagulazione Foundation** · enrollment: 2000 (actual)

## Conditions studied

- Atrial Fibrillation
- Anticoagulant-induced Bleeding

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03803579
- **Lead sponsor:** Arianna Anticoagulazione Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-09
- **Primary completion:** 2022-05-30
- **Final completion:** 2023-05-30
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2023-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03803579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03803579, "Baseline Concentration of Direct Oral Anticoagulant and Incidence of Adverse Event Measure And See (MAS)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03803579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*